• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续性静脉-静脉血液透析滤过联合细胞因子吸附柱改善了一名血液透析患者严重的导管相关血流感染。

CVVHDF combined with cytokine adsorption column ameliorates severe catheter-related bloodstream infection in a hemodialysis patient.

作者信息

Shen Yingjing

机构信息

Department of Nephrology, Shanghai Tianyou Hospital, Shanghai, China.

出版信息

SAGE Open Med Case Rep. 2024 Aug 22;12:2050313X241272670. doi: 10.1177/2050313X241272670. eCollection 2024.

DOI:10.1177/2050313X241272670
PMID:39185073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11342434/
Abstract

In extracorporeal circulation, inflammatory mediators are eliminated through inflammatory cytokine adsorption. By interacting with inflammatory cytokines and removing them from the bloodstream, the adsorber's adsorbent lowers levels of inflammatory mediators and the inflammatory response. We present the case of a 67-year-old Chinese man diagnosed with sepsis due to a bloodstream infection from a catheter. We promptly utilized a cytokine adsorption column in conjunction with continuous veno-venous hemodiafiltration (CVVHDF), resulting in a decrease in interleukin-6 levels and complete removal of bascteria from the bloodstream. A critical turning point in illness management is reached as the levels of inflammatory cytokines drop and the dosage of patients' vasoactive medications improves significantly. In hemodialysis patients with secondary septic shock in the context of catheter-associated bacteremia, the combination of CVVHDF with cytokine adsorption therapy in hemodialysis may be clinically useful and improve or accelerate the patient's improvement.

摘要

在体外循环中,炎症介质通过炎症细胞因子吸附被清除。吸附器的吸附剂与炎症细胞因子相互作用并将其从血液中去除,从而降低炎症介质水平和炎症反应。我们报告一例67岁中国男性病例,该患者因导管引起的血流感染被诊断为脓毒症。我们立即将细胞因子吸附柱与连续性静脉-静脉血液透析滤过(CVVHDF)联合使用,导致白细胞介素-6水平下降且血液中的细菌被完全清除。随着炎症细胞因子水平下降以及患者血管活性药物剂量显著改善,疾病管理达到关键转折点。在导管相关菌血症背景下继发感染性休克的血液透析患者中,CVVHDF与血液透析中的细胞因子吸附疗法联合应用可能具有临床实用性,并可改善或加速患者的康复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/11342434/7b5f139944c4/10.1177_2050313X241272670-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/11342434/7b5f139944c4/10.1177_2050313X241272670-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6de/11342434/7b5f139944c4/10.1177_2050313X241272670-fig1.jpg

相似文献

1
CVVHDF combined with cytokine adsorption column ameliorates severe catheter-related bloodstream infection in a hemodialysis patient.连续性静脉-静脉血液透析滤过联合细胞因子吸附柱改善了一名血液透析患者严重的导管相关血流感染。
SAGE Open Med Case Rep. 2024 Aug 22;12:2050313X241272670. doi: 10.1177/2050313X241272670. eCollection 2024.
2
High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial.高剂量与常规剂量连续静脉-静脉血液滤过对脓毒症相关性急性肾损伤患者和肾脏生存及细胞因子清除的影响:一项随机对照试验。
Am J Kidney Dis. 2016 Oct;68(4):599-608. doi: 10.1053/j.ajkd.2016.02.049. Epub 2016 Apr 12.
3
Feasibility and safety of combined cytokine adsorption and continuous veno-venous hemodialysis with regional citrate anticoagulation in patients with septic shock.细胞因子吸附联合连续性静脉-静脉血液透析并采用局部枸橼酸抗凝在感染性休克患者中的可行性及安全性
Int J Artif Organs. 2020 Jan;43(1):10-16. doi: 10.1177/0391398819866459. Epub 2019 Aug 3.
4
TNF-α depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment.肿瘤坏死因子-α清除是接受持续静脉-静脉血液透析滤过治疗的重症患者死亡率的一个预测指标。
Cytokine. 2015 Feb;71(2):255-60. doi: 10.1016/j.cyto.2014.10.024. Epub 2014 Nov 24.
5
Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.使用聚甲基丙烯酸甲酯(PMMA)膜血液滤过器作为细胞因子调节剂,通过连续性血液透析滤过(CHDF)治疗严重脓毒症和脓毒性休克。
Contrib Nephrol. 2010;166:73-82. doi: 10.1159/000314855. Epub 2010 May 7.
6
Molecular adsorbent recirculating system (MARS) and continuous veno-venous hemodiafiltration (CVVHDF) for diltiazem removal: An in vitro study.分子吸附再循环系统(MARS)和连续静脉-静脉血液透析滤过(CVVHDF)清除地尔硫䓬:一项体外研究。
Int J Artif Organs. 2021 Jul;44(7):489-496. doi: 10.1177/0391398820975041. Epub 2020 Dec 1.
7
Is circulating phospholipase A2 removed by large-pore continuous venovenous hemodiafiltration in septic acute renal failure?在脓毒症急性肾衰竭中,大孔径连续性静脉-静脉血液透析滤过是否能清除循环中的磷脂酶A2?
Ren Fail. 2004 Mar;26(2):127-33. doi: 10.1081/jdi-120038487.
8
Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC®2 Membrane in Patients with Septic Shock.中分子量 cutoff EMiC®2 膜连续性血液透析在感染性休克患者中的临床评估。
Blood Purif. 2022;51(11):912-922. doi: 10.1159/000522321. Epub 2022 Mar 9.
9
Continuous veno-venous hemodiafiltration alleviates multiple organ dysfunction syndrome in dogs.连续性静脉-静脉血液透析滤过缓解犬多器官功能障碍综合征。
Immunopharmacol Immunotoxicol. 2012 Dec;34(6):1001-9. doi: 10.3109/08923973.2012.685630. Epub 2012 May 11.
10
[Pulse indicator continuous cardiac output measurement-guided treatment aids two pediatric patients with severe acute pancreatitis complicated with acute respiratory distress syndrome].[脉搏指示连续心输出量测量指导治疗辅助两名重症急性胰腺炎合并急性呼吸窘迫综合征的儿科患者]
Zhonghua Er Ke Za Zhi. 2014 Sep;52(9):693-8.

本文引用的文献

1
Efficacy of CytoSorb®: a systematic review and meta-analysis.CytoSorb® 的疗效:系统评价和荟萃分析。
Crit Care. 2023 May 31;27(1):215. doi: 10.1186/s13054-023-04492-9.
2
Catheter-Related Blood Stream Infections and Associated Factors Among Hemodialysis Patients in a Tertiary Care Hospital.三级护理医院血液透析患者导管相关血流感染及其相关因素
Infect Drug Resist. 2023 May 22;16:3145-3156. doi: 10.2147/IDR.S409400. eCollection 2023.
3
CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo.
细胞因子吸附血液灌流在体内显著减轻人类全身炎症反应中的循环细胞因子浓度。
Crit Care. 2023 Mar 21;27(1):117. doi: 10.1186/s13054-023-04391-z.
4
Mortality and adverse events of hemoadsorption with CytoSorb® in critically ill patients: A systematic review and meta-analysis of randomized controlled trials.危重症患者使用 CytoSorb®进行血液吸附的死亡率和不良事件:系统评价和随机对照试验的荟萃分析。
Acta Anaesthesiol Scand. 2022 Oct;66(9):1037-1050. doi: 10.1111/aas.14115. Epub 2022 Jul 18.
5
New Targets for Extracorporeal Blood Purification Therapies in Sepsis.脓毒症体外血液净化治疗的新靶点。
Blood Purif. 2023;52(1):1-7. doi: 10.1159/000524973. Epub 2022 Jun 17.
6
Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis.治疗维持性血液透析患者导管相关血流感染的干预措施。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD013554. doi: 10.1002/14651858.CD013554.pub2.
7
Renal Replacement Techniques in Septic Shock.脓毒性休克的肾脏替代治疗技术。
Int J Mol Sci. 2021 Sep 23;22(19):10238. doi: 10.3390/ijms221910238.
8
Role of Hemoperfusion With CytoSorb Associated With Continuous Kidney Replacement Therapy on Renal Outcome in Critically III Children With Septic Shock.细胞吸附剂血液灌流联合持续肾脏替代疗法对脓毒性休克重症患儿肾脏转归的作用
Front Pediatr. 2021 Aug 24;9:718049. doi: 10.3389/fped.2021.718049. eCollection 2021.
9
Cytokine adsorption in severe, refractory septic shock.严重难治性脓毒症休克中的细胞因子吸附
Intensive Care Med. 2021 Nov;47(11):1334-1336. doi: 10.1007/s00134-021-06512-0. Epub 2021 Sep 1.
10
Targeting Cytokines, Pathogen-Associated Molecular Patterns, and Damage-Associated Molecular Patterns in Sepsis via Blood Purification.通过血液净化靶向脓毒症中的细胞因子、病原体相关分子模式和损伤相关分子模式。
Int J Mol Sci. 2021 Aug 18;22(16):8882. doi: 10.3390/ijms22168882.